Editors-in-Chief
Jeroen Hoozemans, Amsterdam University Medical Centers, The Netherlands
Jason Huse, University of Texas MD Anderson Cancer Center, USA
Aims and scope
Acta Neuropathologica Communications (ANC) focuses on the pathogenesis of neurological disease using experimental or human tissues, molecular, cellular, biological and morphological techniques
Thematic Series - Traumatic Brain Injury
We are excited to present a thematic series focusing on clinical, basic science, and translational studies that address current problems and knowledge gaps in TBI, which affects over 65 million people worldwide each year.
This series will feature commissioned and non-commissioned content on topics including prospective biomarkers, mechanistic studies and comorbidity links.
More information can be found here.
Why publish with ANC?
- No major revisions: only minor revisions are requested that can be performed (and have to be performed) within 3 weeks
- Fast, thorough peer review: group of editors selected on the basis of their insightful, dedicated and prompt service
- Rapid publication: publication within 2 months of submission
- Inclusion in all major indexing services, such as PubMed, MEDLINE and Web of Science
- Open access: enabling it to be read by a much larger set of readers, increasing its visibility
- Competitive APC: flat article-processing charge, with no page limits, color figure charges or submission fees
Articles
-
-
Slow motor neurons resist pathological TDP-43 and mediate motor recovery in the rNLS8 model of amyotrophic lateral sclerosis
-
Oligodendrocyte lineage is severely affected in human alcohol-exposed foetuses
-
The distribution and function of GDE2, a regulator of spinal motor neuron survival, are disrupted in Amyotrophic Lateral Sclerosis
-
Changes in glial cell phenotypes precede overt neurofibrillary tangle formation, correlate with markers of cortical cell damage, and predict cognitive status of individuals at Braak III-IV stages
-
Do brain T2/FLAIR white matter hyperintensities correspond to myelin loss in normal aging? A radiologic-neuropathologic correlation study
-
Myelin alters the inflammatory phenotype of macrophages by activating PPARs
-
The prion hypothesis in Parkinson's disease: Braak to the future
-
Possible involvement of lysosomal dysfunction in pathological changes of the brain in aged progranulin-deficient mice
-
Pediatric low-grade glioma in the era of molecular diagnostics
Original Paper, 2013
Do brain T2/FLAIR white matter hyperintensities correspond to myelin loss in normal aging? A radiologic-neuropathologic correlation study
Sven Haller et al.
Original Paper, 2021
APOE ε4 associates with increased risk of severe COVID-19, cerebral microhaemorrhages and post-COVID mental fatigue: a Finnish biobank, autopsy and clinical study
FinnGen
Review Paper, 2020
Pediatric low-grade glioma in the era of molecular diagnostics
Scott Ryall, Uri Tabori, Cynthia Hawkins
Review Paper, 2020
PINK1/PARKIN signalling in neurodegeneration and neuroinflammation
Peter M. J. Quinn et al.
Review Paper, 2020
Biological links between traumatic brain injury and Parkinson’s disease
Vedad Delic, Kevin D. Beck, Kevin C. H. Pang, Bruce A. Citron
From the Editors-in-Chief
"The unique combination of human neuropathology with relevant experimental models is essential for understanding the pathogenesis of neurological diseases. Acta Neuropathologica Communications provides a platform for studies that centrally involve human neuropathology and bring new insight in disease mechanisms of neurological diseases using relevant experimental models. We welcome high quality papers that do not require major revisions, resulting in short turn-around times and fast publication. We hope you enjoy Acta Neuropathologica Communications and are looking forward to receive your submissions."
Jeroen Hoozemans, co-Editor-in-Chief, ANC
"As an original member of the ANC editorial board, it has been a pleasure to witness the growth and maturation of this journal first hand. ANC now occupies a well-defined niche for the rapid publication of high-quality work advancing the broad spectrum of neuropathology and its allied sciences. I look forward to receiving and evaluating your compelling manuscripts in the months and years ahead."
Jason T. Huse, co-Editor-in-Chief, ANC
Follow
Annual Journal Metrics
-
Speed
4 days to first decision for all manuscripts
28 days to first decision for reviewed manuscripts only
44 days from submission to acceptance
19 days from acceptance to publicationCitation Impact
7.801 - 2-Year impact factor
8.064 - 5-Year impact factor
1.18 - Source Normalized Impact per Paper (SNIP)
3.131 - SCImago Journal Rank (SJR)Usage
1,147,908 downloads (2021)
1,631 altmetric mentions